87.43
-3.20
(-3.53%)
At close: January 10 at 4:00:02 PM EST
87.43
0.00
(0.00%)
After hours: January 10 at 5:03:38 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-242,150.00
-436,847.00
-502,277.00
-298,653.00
387,035.00
Investing Cash Flow
-2,441.00
274,040.00
-149,541.00
-225,860.00
-434,249.00
Financing Cash Flow
278,880.00
119,225.00
561,810.00
50,716.00
617,759.00
End Cash Position
99,957.00
81,524.00
124,904.00
215,119.00
689,804.00
Income Tax Paid Supplemental Data
--
--
6,505.00
694.00
778.00
Interest Paid Supplemental Data
69,067.00
38,467.00
9,814.00
--
--
Capital Expenditure
-8,371.00
-16,062.00
-8,919.00
-261,241.00
-3,159.00
Issuance of Capital Stock
--
--
--
--
582,494.00
Issuance of Debt
146,938.00
97,933.00
137,786.00
--
--
Free Cash Flow
-250,521.00
-452,909.00
-511,196.00
-559,894.00
383,876.00
12/31/2020 - 4/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NUVL Nuvalent, Inc.
76.61
-2.10%
ACLX Arcellx, Inc.
69.08
-4.40%
RARE Ultragenyx Pharmaceutical Inc.
42.07
-3.62%
SWTX SpringWorks Therapeutics, Inc.
43.00
+6.20%
JANX Janux Therapeutics, Inc.
46.76
-7.99%
CYTK Cytokinetics, Incorporated
46.62
-1.58%
EWTX Edgewise Therapeutics, Inc.
24.15
-5.00%
PTCT PTC Therapeutics, Inc.
43.94
-2.44%
AGIO Agios Pharmaceuticals, Inc.
34.42
-4.12%
DNLI Denali Therapeutics Inc.
19.10
-10.12%